跳至主導覽
跳至搜尋
跳過主要內容
臺北醫學大學 首頁
說明與常見問題
English
中文
首頁
專家檔案
研究單位
專案
研究成果
資料集
活動
按專業知識、姓名或所屬機構搜尋
查看斯高帕斯 (Scopus) 概要
劉 家宏
副教授
,
泌尿學科
成員
,
臺北醫學大學泌尿腎臟研究中心
主治醫師
,
衛生福利部雙和醫院
https://orcid.org/0000-0003-2327-1295
電子郵件
mexxliu
tmu.edu
tw
h-index
1277
引文
18
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
2010
2024
每年研究成果
概覽
指紋
網路
專案
(5)
研究成果
(45)
類似的個人檔案
(6)
指紋
查看啟用 Chia-Hung Liu 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Pharmacology, Toxicology and Pharmaceutical Science
Nanoparticle
80%
Alginic Acid
50%
Thrombus
36%
Bladder Cancer
32%
Photothermal Therapy
31%
Neoplasm
31%
Fibrinolytic Agent
30%
Gold Nanorod
29%
Hydroxyapatite
29%
Mouse Model
25%
Inflammation
25%
Polypyrrole
24%
Intracellular Drug Delivery
22%
Metal Organic Framework
22%
Thrombosis
21%
Biocompatibility
20%
Mouth Squamous Cell Carcinoma
19%
Microsphere
19%
Hyperthermia
19%
Chitosan
19%
Prostate Cancer
19%
Chronic Kidney Failure
16%
Chlamydomonas reinhardtii
16%
Drug Delivery System
16%
Chemotherapy
15%
Injury
15%
Iron Oxide
14%
Fucoidan
14%
P-Selectin
11%
Nanocarrier
11%
Kidney Fibrosis
10%
Nanomaterial
10%
Liver Cancer
10%
Mouse
10%
Pembrolizumab
9%
Mesoporous Silica Nanoparticle
9%
Prostate Specific Antigen
9%
Withaferin A
9%
Polyacrylic Acid
9%
Ureter Obstruction
9%
Calcium Phosphate
9%
Apoptosis Inhibitor
9%
2,5-Dimethoxy-4-iodoamphetamine
9%
Amino Acid
9%
Monocyte Chemotactic Protein 1
9%
Magnesium Ion
9%
Cisplatin
9%
Narcotic Agent
9%
Nanoclusters
9%
Dipyridamole
9%
Medicine and Dentistry
Thrombus
31%
Blood Clot Lysis
22%
Thrombolytic Drug
21%
Thrombosis
20%
Platelet
19%
Ischemic Injury
12%
Nanoparticle
11%
Photothermal Therapy
11%
PADGEM Protein
11%
Gold Nanorod
9%
Injury
9%
Apoptosis Inhibitor
9%
Prostate Specific Antigen
9%
Genitourinary System
9%
Macrophage
9%
Prostate Cancer
9%
Extracorporeal Shock Wave Lithotripsy
9%
Urethra Stenosis
9%
Urethrotomy
9%
Urolithiasis
9%
Microhematuria
9%
Mouth Squamous Cell Carcinoma
9%
Hemostat
9%
Magnesium Ion
9%
Magnesium
9%
Osteoplasty
9%
Polyacrylic Acid
9%
Metal Organic Framework
9%
4 Iodo 2,5 Dimethoxyamphetamine
9%
Percutaneous Nephrolithotomy
9%
Biomimetics
9%
Dipyridamole
9%
Pembrolizumab
9%
Bone Regeneration
9%
Bioglass
9%
Ultrasmall Superparamagnetic Iron Oxide
9%
Orthopedics
9%
Hyperthermia
9%
Ischemia
9%
Side Effect
9%
Targeted Therapy
9%
Inflammatory Disorder
9%
Nanocarrier
9%
Platelet Lysate
9%
Polypyrrole
9%
Diabetes
9%
Diabetes Mellitus
9%
Functional Disease
9%
Smooth Muscle Relaxation
9%
Recurrent Disease
6%
Material Science
Nanoparticle
100%
Iron Oxide
45%
Metal-Organic Framework
39%
Platelet
39%
Biocompatibility
28%
Tumor
20%
Thin Films
19%
Polypyrrole
17%
Macrophage
16%
Hydrogel
14%
Curcumin
14%
Nanocrystalline Material
13%
Molybdenum
11%
Magnesium Ion
9%
Molybdate
9%
Nanorod
9%
Amino Acids
9%
Silicon Dioxide
9%
Polymer Nanoparticles
9%
Magnesium
9%
Titanium Dioxide
9%
Platinum
9%
Surface Texture
9%
Aluminum Oxide
9%
Polysiloxane
9%
Nanoclusters
9%
Bioglass
9%
Nanozymes
9%
Gold Nanoparticle
5%
